Order Article Reprints

Berclaz LM, Altendorf-Hofmann A, Dürr HR, Klein A, Angele MK, Albertsmeier M, Schmidt-Hegemann N-S, Di Gioia D, Knösel T, Lindner LH. Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy. Cancers. 2021; 13(19):4877. https://doi.org/10.3390/cancers13194877

Berclaz, Luc M., Annelore Altendorf-Hofmann, Hans Roland Dürr, Alexander Klein, Martin K. Angele, Markus Albertsmeier, Nina-Sophie Schmidt-Hegemann, Dorit Di Gioia, Thomas Knösel, and Lars H. Lindner. 2021. "Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy" Cancers 13, no. 19: 4877. https://doi.org/10.3390/cancers13194877

Berclaz, L. M., Altendorf-Hofmann, A., Dürr, H. R., Klein, A., Angele, M. K., Albertsmeier, M., Schmidt-Hegemann, N.-S., Di Gioia, D., Knösel, T., & Lindner, L. H. (2021). Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy. Cancers, 13(19), 4877. https://doi.org/10.3390/cancers13194877